Manufacturer of Controlled Substances; Notice of Registration; American Radiolabeled Chemicals, Inc., 52368-52369 [2012-21281]
Download as PDF
52368
Federal Register / Vol. 77, No. 168 / Wednesday, August 29, 2012 / Notices
Dated: August 17, 2012.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
Dated: August 17, 2012.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. 2012–21280 Filed 8–28–12; 8:45 am]
[FR Doc. 2012–21283 Filed 8–28–12; 8:45 am]
BILLING CODE 4410–09–P
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Drug Enforcement Administration
Manufacturer of Controlled
Substances; Notice of Registration;
Agilent Technologies
Manufacturer of Controlled
Substances; Notice of Registration;
Austin Pharma, LLC.
By Notice dated May 9, 2012, and
published in the Federal Register on
May 21, 2012, 77 FR 30027, Austin
Pharma LLC., 811 Paloma Drive, Suite
C, Round Rock, Texas 78665–2402,
made application by renewal to the
Drug Enforcement Administration
(DEA) to be registered as a bulk
manufacturer of the following basic
classes of controlled substances:
By Notice dated May 11, 2012, and
published in the Federal Register on
May 21, 2012, 77 FR 30025, Agilent
Technologies, 25200 Commercentre
Drive, Lake Forest, California 92630–
8810, made application by renewal to
the Drug Enforcement Administration
(DEA) to be registered as a bulk
manufacturer of the following basic
classes of controlled substances:
Drug
Drug
Schedule
TKELLEY on DSK3SPTVN1PROD with NOTICES
Marihuana (7360) .........................
Tetrahydrocannabinols (7370) .....
I
I
The company plans to manufacture
bulk active pharmaceutical ingredients
(APIs) for distribution to its customers.
In reference to drug code 7360
(Marihuana), the company plans to bulk
manufacture cannabidiol as a synthetic
intermediate. This controlled substance
will be further synthesized to bulk
manufacture a synthetic THC (7370). No
other activity for this drug code is
authorized for this registration.
No comments or objections have been
received. DEA has considered the
factors in 21 U.S.C. 823(a) and
determined that the registration of
Austin Pharma LLC., to manufacture the
listed basic classes of controlled
substances is consistent with the public
interest at this time. DEA has
investigated Austin Pharma LLC., to
ensure that the company’s registration is
consistent with the public interest. The
investigation has included inspection
and testing of the company’s physical
security systems, verification of the
company’s compliance with state and
local laws, and a review of the
company’s background and history.
Therefore, pursuant to 21 U.S.C. 823,
and in accordance with 21 CFR
§ 1301.33, the above named company is
granted registration as a bulk
manufacturer of the basic classes of
controlled substances listed.
VerDate Mar<15>2010
18:51 Aug 28, 2012
Jkt 226001
Schedule
Phencyclidine (7471) ....................
1-piperidinocyclohexanecarboni
trile (8603).
Benzoylecgonine (9180) ...............
II
II
II
The company plans to manufacture
small quantities of the listed controlled
substances for use in diagnostic
products.
No comments or objections have been
received. DEA has considered the
factors in 21 U.S.C. 823(a) and
determined that the registration of
Agilent Technologies to manufacture
the listed basic classes of controlled
substances is consistent with the public
interest at this time. DEA has
investigated Agilent Technologies to
ensure that the company’s registration is
consistent with the public interest. The
investigation has included inspection
and testing of the company’s physical
security systems, verification of the
company’s compliance with state and
local laws, and a review of the
company’s background and history.
Therefore, pursuant to 21 U.S.C. 823(a),
and in accordance with 21 CFR
§ 1301.33, the above named company is
granted registration as a bulk
manufacturer of the basic classes of
controlled substances listed.
Dated: August 17, 2012.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. 2012–21282 Filed 8–28–12; 8:45 am]
BILLING CODE 4410–09–P
PO 00000
Frm 00060
Fmt 4703
Sfmt 4703
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled
Substances; Notice of Registration;
American Radiolabeled Chemicals, Inc.
By Notice dated May 9, 2012, and
published in the Federal Register on
May 21, 2012, 77 FR 30027, American
Radiolabeled Chemicals, INC., 101 Arc
Drive, St. Louis, Missouri 63146, made
application by renewal to the Drug
Enforcement Administration (DEA) to
be registered as a bulk manufacturer of
the following basic classes of controlled
substances:
Drug
Gamma
Hydroxybutyric
Acid
(2010).
Ibogaine (7260) ............................
Lysergic acid diethylamide (7315)
Tetrahydrocannabinols (7370) .....
Dimethyltryptamine (7435) ...........
1-[1-(2Thienyl)cyclohexyl]piperidine
(7470).
Dihydromorphine (9145) ...............
Normorphine (9313) .....................
Heroin (9200) ...............................
Amphetamine (1100) ....................
Methamphetamine (1105) ............
Amobarbital (2125) .......................
Phencyclidine (7471) ....................
Phenylacetone (8501) ..................
Cocaine (9041) .............................
Codeine (9050) .............................
Dihydrocodeine (9120) .................
Oxycodone (9143) ........................
Hydromorphone (9150) ................
Ecgonine (9180) ...........................
Hydrocodone (9193) .....................
Meperidine (9230) ........................
Metazocine (9240) ........................
Dextropropoxyphene, bulk (nondosage forms) (9273).
Morphine (9300) ...........................
Oripavine (9330) ...........................
Thebaine (9333) ...........................
Oxymorphone (9652) ...................
Phenazocine (9715) .....................
Carfentanil (9743) .........................
Fentanyl (9801) ............................
Schedule
I
I
I
I
I
I
I
I
I
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
The company plans to manufacture
small quantities of the listed controlled
substances as radiolabeled compounds
for biochemical research.
No comments or objections have been
received. DEA has considered the
factors in 21 U.S.C. 823(a) and
determined that the registration of
American Radiolabeled Chemicals,
INC., to manufacture the listed basic
classes of controlled substances is
consistent with the public interest at
this time. DEA has investigated
American Radiolabeled Chemicals INC.,
to ensure that the company’s
registration is consistent with the public
E:\FR\FM\29AUN1.SGM
29AUN1
Federal Register / Vol. 77, No. 168 / Wednesday, August 29, 2012 / Notices
interest. The investigation has included
inspection and testing of the company’s
physical security systems, verification
of the company’s compliance with state
and local laws, and a review of the
company’s background and history.
Therefore, pursuant to 21 U.S.C. 823(a),
and in accordance with 21 CFR
§ 1301.33, the above named company is
granted registration as a bulk
manufacturer of the basic classes of
controlled substances listed.
Dated: August 17, 2012.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
manufacturer of the basic classes of
controlled substances listed.
Dated: August 17, 2012.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. 2012–21279 Filed 8–28–12; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Office of Justice Programs
[OMB Number 1121–0259]
Agency Information Collection
Activities; Proposed Collection;
Comments Requested: Bureau of
Justice Assistance Application Form:
Public Safety Officer’s Medal of Valor
[FR Doc. 2012–21281 Filed 8–28–12; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
60-Day Notice of Information
Collection Under Review.
ACTION:
Drug Enforcement Administration
Manufacturer of Controlled
Substances; Notice of Registration;
Stepan Company
By Notice dated May 11, 2012, and
published in the Federal Register on
May 21, 2012, 77 FR 30026, Stepan
Company, Natural Products Dept., 100
W. Hunter Avenue, Maywood, New
Jersey 07607, made application by
renewal to the Drug Enforcement
Administration (DEA) to be registered as
a bulk manufacturer of the following
basic classes of controlled substances:
Drug
Schedule
TKELLEY on DSK3SPTVN1PROD with NOTICES
Cocaine (9041) II ..........................
Ecgonine (9180) II ........................
II
II
The company plans to manufacture
the listed controlled substances in bulk
for distribution to its customers.
No comments or objections have been
received. DEA has considered the
factors in 21 U.S.C. 823(a), and
determined that the registration of
Stepan Company to manufacture the
listed basic classes of controlled
substances is consistent with the public
interest at this time.
DEA has investigated Stepan
Company to ensure that the company’s
registration is consistent with the public
interest. The investigation has included
inspection and testing of the company’s
physical security systems, verification
of the company’s compliance with state
and local laws, and a review of the
company’s background and history.
Therefore, pursuant to 21 U.S.C.
823(a), and in accordance with 21 CFR
§ 1301.33, the above named company is
granted registration as a bulk
VerDate Mar<15>2010
17:37 Aug 28, 2012
Jkt 226001
The Department of Justice (DOJ),
Office of Justice Programs (OJP), will be
submitting the following information
collection request to the Office of
Management and Budget (OMB) for
review and approval in accordance with
the Paperwork Reduction Act of 1995.
The proposed information collection is
published to obtain comments from the
public and affected agencies. Comments
are encouraged and will be accepted for
‘‘sixty days’’ until October 29, 2012.
This process is conducted in accordance
with 5 CFR 1320.10.
If you have comments especially on
the estimated public burden or
associated response time, suggestions,
or need a copy of the proposed
information collection instrument with
instructions or additional information,
please contact Maria A. Berry, Senior
Advisor by email at
M.A.Berry@ojp.usdoj.gov or by
telephone at 202–353–8643, Bureau of
Justice Assistance, Office of Justice
Programs, U.S. Department of Justice,
810 Seventh Street NW., Washington,
DC 20531.
Written comments and suggestions
from the public and affected agencies
concerning the proposed collection of
information are encouraged. Your
comments should address one or more
of the following four points:
—Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
—Evaluate the accuracy of the agency’s
estimate of the burden of the
proposed collection of information,
PO 00000
Frm 00061
Fmt 4703
Sfmt 4703
52369
including the validity of the
methodology and assumptions used;
—Enhance the quality, utility, and
clarity of the information to be
collected; and
—Minimize the burden of the collection
of information on those who are to
respond, including through the use of
appropriate automated, electronic,
mechanical, or other technological
collection techniques or other forms
of information technology, e.g.,
permitting electronic submission of
responses.
Overview of This Information
Collection
(1) Type of Information Collection:
Extension of a currently approved
collection.
(2) Title of the Form/Collection:
Bureau of Justice Assistance
Application Form: Public Safety
Officers Medal of Valor.
(3) Agency form number, if any, and
the applicable component of the
Department of Justice sponsoring the
collection: Form Number: None.
(4) Affected public who will be asked
or required to respond, as well as a brief
Abstract: Primary: State, local and tribal
government agencies within the United
States and its territories.
Abstract: The Bureau of Justice
Assistance, a component of the Office of
Justice Program, Department of Justice,
administers the Public Safety Officer’s
Medal of Valor. Once a year, the
President of the United States of
America may award, and present in the
name of Congress, a Medal of Valor of
appropriate design, with ribbons and
appurtenances, to a public safety officer
who is cited by the Attorney General,
upon the recommendation of the Medal
of Valor Review Board, for extraordinary
valor above and beyond the call of duty.
The Public Safety Officer Medal of Valor
is the highest national award given to a
public safety officer in recognition of
their bravery and altruistic acts of valor
to protect and save the lives of others.
Nomination(s) for this award is
voluntary.
Nominations are received through the
Internet, or postal mail. The Medal of
Valor program is governed by F1.R.802,
the ‘‘Public Safety Officer Medal of
Valor Act of 2001.
(5) An estimate of the total number of
respondents and the amount of time
estimated for an average respondent to
respond/reply: It is estimated that it will
take the 225 applicants under the Medal
of Valor approximately 25 minutes to
complete the application form.
(6) An estimate of the total public
burden (in hours) associated with the
Collection. The total estimated annual
E:\FR\FM\29AUN1.SGM
29AUN1
Agencies
[Federal Register Volume 77, Number 168 (Wednesday, August 29, 2012)]
[Notices]
[Pages 52368-52369]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-21281]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled Substances; Notice of Registration;
American Radiolabeled Chemicals, Inc.
By Notice dated May 9, 2012, and published in the Federal Register
on May 21, 2012, 77 FR 30027, American Radiolabeled Chemicals, INC.,
101 Arc Drive, St. Louis, Missouri 63146, made application by renewal
to the Drug Enforcement Administration (DEA) to be registered as a bulk
manufacturer of the following basic classes of controlled substances:
------------------------------------------------------------------------
Drug Schedule
------------------------------------------------------------------------
Gamma Hydroxybutyric Acid (2010)........... I
Ibogaine (7260)............................ I
Lysergic acid diethylamide (7315).......... I
Tetrahydrocannabinols (7370)............... I
Dimethyltryptamine (7435).................. I
1-[1-(2-Thienyl)cyclohexyl]piperidine I
(7470).
Dihydromorphine (9145)..................... I
Normorphine (9313)......................... I
Heroin (9200).............................. I
Amphetamine (1100)......................... II
Methamphetamine (1105)..................... II
Amobarbital (2125)......................... II
Phencyclidine (7471)....................... II
Phenylacetone (8501)....................... II
Cocaine (9041)............................. II
Codeine (9050)............................. II
Dihydrocodeine (9120)...................... II
Oxycodone (9143)........................... II
Hydromorphone (9150)....................... II
Ecgonine (9180)............................ II
Hydrocodone (9193)......................... II
Meperidine (9230).......................... II
Metazocine (9240).......................... II
Dextropropoxyphene, bulk (non-dosage forms) II
(9273).
Morphine (9300)............................ II
Oripavine (9330)........................... II
Thebaine (9333)............................ II
Oxymorphone (9652)......................... II
Phenazocine (9715)......................... II
Carfentanil (9743)......................... II
Fentanyl (9801)............................ II
------------------------------------------------------------------------
The company plans to manufacture small quantities of the listed
controlled substances as radiolabeled compounds for biochemical
research.
No comments or objections have been received. DEA has considered
the factors in 21 U.S.C. 823(a) and determined that the registration of
American Radiolabeled Chemicals, INC., to manufacture the listed basic
classes of controlled substances is consistent with the public interest
at this time. DEA has investigated American Radiolabeled Chemicals
INC., to ensure that the company's registration is consistent with the
public
[[Page 52369]]
interest. The investigation has included inspection and testing of the
company's physical security systems, verification of the company's
compliance with state and local laws, and a review of the company's
background and history. Therefore, pursuant to 21 U.S.C. 823(a), and in
accordance with 21 CFR Sec. 1301.33, the above named company is
granted registration as a bulk manufacturer of the basic classes of
controlled substances listed.
Dated: August 17, 2012.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. 2012-21281 Filed 8-28-12; 8:45 am]
BILLING CODE 4410-09-P